title: Letter by Escobar et al Regarding Article, "On-Treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With Warfarin: Insights From ROCKET AF".
authors.affiliation: From Cardiology Department, Hospital Universitario La Paz, Madrid, Spain (C.E.); Cardiology Department, Hospital Ramon y Cajal, Department of Medicine, University of Alcala de Henares, Madrid, Spain (V.B.); and Nephrology Department, Hospital Doctor Peset, Department of Medicine, University of Valencia, Spain (J.L.G.).
authors.forename: Carlos
authors.initials: C
authors.lastname: Escobar
authors.affiliation: From Cardiology Department, Hospital Universitario La Paz, Madrid, Spain (C.E.); Cardiology Department, Hospital Ramon y Cajal, Department of Medicine, University of Alcala de Henares, Madrid, Spain (V.B.); and Nephrology Department, Hospital Doctor Peset, Department of Medicine, University of Valencia, Spain (J.L.G.).
authors.forename: Vivencio
authors.initials: V
authors.lastname: Barrios
authors.affiliation: From Cardiology Department, Hospital Universitario La Paz, Madrid, Spain (C.E.); Cardiology Department, Hospital Ramon y Cajal, Department of Medicine, University of Alcala de Henares, Madrid, Spain (V.B.); and Nephrology Department, Hospital Doctor Peset, Department of Medicine, University of Valencia, Spain (J.L.G.).
authors.forename: Jose Luis
authors.initials: JL
authors.lastname: Gorriz
mesh_terms: D000925:Anticoagulants; D001281:Atrial Fibrillation; D065427:Factor Xa Inhibitors; D006801:Humans; D000069552:Rivaroxaban; D020521:Stroke; D016896:Treatment Outcome; D014859:Warfarin
chemical_list: D000925:Anticoagulants; D065427:Factor Xa Inhibitors; D014859:Warfarin; D000069552:Rivaroxaban